Summary of Stock Option Activity (Details) - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Share-Based Payment Arrangement [Abstract] | ||
| Number of shares, outstanding beginning balance | 33,150 | |
| Weighted average exercise price, outstanding beginning balance | $ 142.71 | |
| Weighted average remaining contractual term (in years), outstanding ending | 8 years 14 days | 6 years 8 months 19 days |
| Aggregate intrinsic value, outstanding, balance | ||
| Number of shares, cancelled or expired | (9,138) | |
| Weighted average exercise price, cancelled or expired | $ 105.90 | |
| Number of shares, outstanding ending balance | 24,012 | 33,150 |
| Weighted average exercise price, outstanding ending balance | $ 156.72 | $ 142.71 |
| Aggregate intrinsic value, outstanding balance | ||
| Number of shares, exercisable balance | 22,844 | |
| Weighted average exercise price, exercisable balance | $ 164.00 | |
| Weighted average remaining contractual term (in years), exercisable | 7 years 11 months 23 days | |
| Aggregate intrinsic value, exercisable balance |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options exercisable. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|